NCT00923442View on ClinicalTrials.gov

Biology Studies of Hematologic Cancers

Enrolling by invitationOBSERVATIONAL
Enrollment

550

Participants

Timeline

Start Date

February 24, 2004

Conditions
Acute Lymphoblastic LeukemiaMyelodysplastic Syndrome (MDS)Non-Hodgkins LymphomaAcute Myelogenous LeukemiaHodgkins Lymphoma
Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00923442 - Biology Studies of Hematologic Cancers | Biotech Hunter | Biotech Hunter